Publication: Through the glass darkly: Intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer
Issued Date
2013-12-01
Resource Type
ISSN
10969896
00223417
00223417
Other identifier(s)
2-s2.0-84887548932
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Pathology. Vol.231, No.4 (2013), 402-412
Suggested Citation
Christopher P. Crum, Michael Herfs, Gang Ning, Jonathan G. Bijron, Brooke E. Howitt, Cynthia A. Jimenez, Suchanan Hanamornroongruang, Frank D. McKeon, Wa Xian Through the glass darkly: Intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer. Journal of Pathology. Vol.231, No.4 (2013), 402-412. doi:10.1002/path.4263 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/32065
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Through the glass darkly: Intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer
Abstract
It is currently hoped that deaths from extra-uterine high-grade serous cancer (HGSC) will be reduced via opportunistic salpingectomy in healthy women. Accumulated data implicate the fimbria as a site of origin and descriptive molecular pathology and experimental evidence strongly support a serous carcinogenic sequence in the Fallopian tube. Both direct and indirect ('surrogate') precursors suggest that the benign tube undergoes important biological changes after menopause, acquiring abnormalities in gene expression that are often shared with malignancy, including PAX2, ALDH1, LEF1, RCN1, RUNX2, beta-catenin, EZH2, and others. However, the tube can be linked to only some HGSCs, recharging arguments that nearby peritoneum/ovarian surface epithelium (POSE) also hosts progenitors to this malignancy. A major sticking point is the difference in immunophenotype between POSE and Müllerian epithelium, essentially requiring mesothelial to Müllerian differentiation prior to or during malignant transformation to HGSC. However, emerging evidence implicates an embryonic or progenitor phenotype in the adult female genital tract with the capacity to differentiate, normally or during neoplastic transformation. Recently, a putative cell of origin for cervical cancer has been identified in the squamo-columnar (SC) junction, projecting a model whereby Krt7+ embryonic progenitors give rise to immunophenotypically distinct progeny under stromal influences via 'top down' differentiation. Similar differentiation can be seen in the endometrium with a parallel in juxtaposed mesothelial and Müllerian differentiation in the ovary. Abrupt mesothelial-Müllerian transitions remain to be proven, but would explain the rapid evolution, short asymptomatic interval, and absence of a defined epithelial starting point in many HGSCs. Resolving this question will require accurately distinguishing progenitor from progeny tumour cells in HGSC and pinpointing where initial transformation and trans-differentiation occur, whether in the tube or POSE. Both will be critical to expectations from prophylactic salpingectomy and future approaches to pelvic serous cancer prevention. Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.